OPDP Plans To Survey HCPs About Bad Ad Program and Other Issues
August 12, 2024 at 01:03 PM EST
Researchers with the FDA’s Office of Prescription Drug Promotion (OPDP) are planning to survey health care providers (HPCs) on several topics, including their awareness and use of FDA’s Bad Ad program.
The researchers plan to conduct a 20-minute online survey of 2,410 primary care physicians (PCPs) in family practice, general practice, or internal medicine, nurse practitioner... Read More
